Tech Company Financing Transactions
Ro Funding Round
Ro, based in New York, secured $500 million from FirstMark Capital, General Catalyst Partners and TQ Ventures.
Transaction Overview
Company Name
Announced On
3/24/2021
Transaction Type
Venture Equity
Amount
$500,000,000
Round
Series D
Investors
FirstMark Capital (Lead Investor) (Richard Heitzmann)
General Catalyst Partners (Lead Investor)
TQ Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to strengthen its vertically integrated primary care platform, expand its pharmacy distribution network, continue to enhance its proprietary EMR (the Ro Collaborative Care Center), build new capabilities such as remote patient monitoring with integrated devices, and broaden into additional treatment areas that leverage its diagnostic capabilities.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
116 W 23rd St.
New York, NY 10011
USA
New York, NY 10011
USA
Phone
Website
Email Address
Overview
Ro is a patient-driven telehealth company that puts you in control of your health. We're patients, just like you, building technology to make healthcare accessible, affordable, and maybe even enjoyable. Today, we enable you to connect with a doctor and get treatment when and where you need it. Tomorrow, we aspire to be your first call for all your healthcare needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Saman Rahmanian
Founder
Zachariah Reitano
Founder
Robert Schutz
Browse more venture capital transactions:
Prev: 3/24/2021: Eat Just venture capital transaction
Next: 3/24/2021: Stuart Therapeutics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs